Cargando…

Value Assessment of Oncology Pharmacist Interventions

A review of the published literature confirms the challenge in quantifying the value of oncology pharmacists. This editorial expands on a 2020 study by Meleis and colleagues published in the Journal of the Advanced Practitioner in Oncology and seeks to correlate pharmacist interventions to cost-savi...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Mallika P., Barbour, Sally Y., Moorman, Meredith T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258854/
https://www.ncbi.nlm.nih.gov/pubmed/37313275
http://dx.doi.org/10.6004/jadpro.2023.14.4.7
_version_ 1785057549306822656
author Patel, Mallika P.
Barbour, Sally Y.
Moorman, Meredith T.
author_facet Patel, Mallika P.
Barbour, Sally Y.
Moorman, Meredith T.
author_sort Patel, Mallika P.
collection PubMed
description A review of the published literature confirms the challenge in quantifying the value of oncology pharmacists. This editorial expands on a 2020 study by Meleis and colleagues published in the Journal of the Advanced Practitioner in Oncology and seeks to correlate pharmacist interventions to cost-saving and cost-avoidance measures to show the value of ambulatory oncology clinical pharmacists in patient care. A total of 4,686 interventions were reviewed. The 6-month intervention data demonstrate an annualized value of approximately $1.1 million dollars from nine ambulatory oncology clinical pharmacists showcasing the essential role of the clinical pharmacist in ambulatory oncology settings.
format Online
Article
Text
id pubmed-10258854
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-102588542023-06-13 Value Assessment of Oncology Pharmacist Interventions Patel, Mallika P. Barbour, Sally Y. Moorman, Meredith T. J Adv Pract Oncol Practice Matters A review of the published literature confirms the challenge in quantifying the value of oncology pharmacists. This editorial expands on a 2020 study by Meleis and colleagues published in the Journal of the Advanced Practitioner in Oncology and seeks to correlate pharmacist interventions to cost-saving and cost-avoidance measures to show the value of ambulatory oncology clinical pharmacists in patient care. A total of 4,686 interventions were reviewed. The 6-month intervention data demonstrate an annualized value of approximately $1.1 million dollars from nine ambulatory oncology clinical pharmacists showcasing the essential role of the clinical pharmacist in ambulatory oncology settings. Harborside Press LLC 2023-05 2023-05-01 /pmc/articles/PMC10258854/ /pubmed/37313275 http://dx.doi.org/10.6004/jadpro.2023.14.4.7 Text en © 2023 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Practice Matters
Patel, Mallika P.
Barbour, Sally Y.
Moorman, Meredith T.
Value Assessment of Oncology Pharmacist Interventions
title Value Assessment of Oncology Pharmacist Interventions
title_full Value Assessment of Oncology Pharmacist Interventions
title_fullStr Value Assessment of Oncology Pharmacist Interventions
title_full_unstemmed Value Assessment of Oncology Pharmacist Interventions
title_short Value Assessment of Oncology Pharmacist Interventions
title_sort value assessment of oncology pharmacist interventions
topic Practice Matters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258854/
https://www.ncbi.nlm.nih.gov/pubmed/37313275
http://dx.doi.org/10.6004/jadpro.2023.14.4.7
work_keys_str_mv AT patelmallikap valueassessmentofoncologypharmacistinterventions
AT barboursallyy valueassessmentofoncologypharmacistinterventions
AT moormanmereditht valueassessmentofoncologypharmacistinterventions